Cambium/xylem-preferred promoters and uses thereof

Details for Australian Patent Application No. 2005230212 (hide)

Owner Alellyx S.A.

Inventors Papes, Fabio; Gerhardt, Isabel Rodrigues; Arruda, Paulo

Agent Griffith Hack

Pub. Number AU-B-2005230212

PCT Pub. Number WO2005/096805

Priority 60/560,227 06.04.04 US

Filing date 28 March 2005

Wipo publication date 20 October 2005

Acceptance publication date 28 January 2010

International Classifications

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

A01H 5/00 (2006.01) Products

C12N 5/14 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Plant cells

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C12N 15/82 (2006.01) Mutation or genetic engineering - for plant cells

Event Publications

26 October 2006 PCT application entered the National Phase

  PCT publication WO2005/096805 Priority application(s): WO2005/096805

28 January 2010 Application Accepted

  Published as AU-B-2005230212

27 May 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005230232-Diphenyl-indol-2-on compounds and their use in the treatment of cancer

2005230211-A hearing testing device